HCA Healthcare, Inc.’s Stock Price Skyrockets to $332.00, Marking a Robust 6.05% Increase

HCA Healthcare, Inc. (HCA)

332.00 USD +18.93 (+6.05%) Volume: 2.73M

HCA Healthcare, Inc.’s stock price is currently strong at 332.00 USD, experiencing a robust growth of +6.05% this trading session with a high trading volume of 2.73M. The company’s stock has shown steady performance with a year-to-date increase of +9.93%, making it a promising choice for investors.

Latest developments on HCA Healthcare, Inc.

Following a series of analyst reports and financial updates, HCA Healthcare’s stock price experienced fluctuations today. Mizuho maintained an Outperform rating with a target of $425, while TD Cowen lowered their target to $377. Despite this, HCA Healthcare’s stock was trading up 5% after strong Q4 earnings. Bank of America also adjusted their expectations for the stock price. Ondine Biomedical received a $4 million investment from an HCA Healthcare subsidiary, impacting both companies’ stock movements. Overall, HCA Healthcare’s performance in Q4 2024 was resilient amidst challenges, leading to varying reactions from analysts and investors.

A look at HCA Healthcare, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Looking at the Smart Scores for HCA Healthcare, it seems the company has a positive long-term outlook. With high scores in Momentum and Dividend, the company appears to be performing well in terms of growth and providing returns to investors. However, the lower scores in Value and Resilience indicate potential areas of concern that investors may want to keep an eye on.

HCA Healthcare, Inc. is a healthcare services provider in the United States. Offering a range of services including diagnosis, treatments, surgeries, and medical education, the company serves patients across the country. With moderate scores in Growth and Resilience, HCA Healthcare seems to be on a steady path for future development, while its strong Momentum score suggests a positive trend in the company’s performance.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma